Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rosanna Santoro & Alessandra Mangia. (2019) Progress in promising anti-fibrotic therapies. Expert Review of Gastroenterology & Hepatology 13:12, pages 1145-1152.
Read now
Read now
Articles from other publishers (25)
Lan‐Qing Li & En‐Qiang Chen. (2023)
Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all
CHB
patients with compensated cirrhosis
. Alimentary Pharmacology & Therapeutics 57:12, pages 1467-1468.
Crossref
Crossref
Yufeng Xing, Weichao Zhong, Deti Peng, Zhiyi Han, Hua Zeng, Yanqing Wang, Lian Feng, Jinzhen Huang, Linyi Xu, Mingtai Chen, Daqiao Zhou, Kaiping Jiang, Xin Deng, Hua Zhou & Guangdong Tong. (2023) Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial. Pharmacological Research 190, pages 106737.
Crossref
Crossref
Melissa Borgia, Michele Dal Bo & Giuseppe Toffoli. (2021) Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers 13:17, pages 4387.
Crossref
Crossref
Hong-lian Gui, Chang-qing Zhao, Yan Wang, Hong-tu Gu, Wei-jing Wang, Wei Cai, Qing Guo, Shi-san Bao, Lie-ming Xu & Qing Xie. (2020) Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. Journal of Clinical and Translational Hepatology 8:3, pages 1-8.
Crossref
Crossref
Yi Shen, Yulong Jia, Jie Zhou, Juling Ji & Pengcheng Xun. (2019) Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs. Clinical Drug Investigation 39:9, pages 835-846.
Crossref
Crossref
Aastha Jindal, Anusha Thadi & Kunwar Shailubhai. (2019) Hepatocellular Carcinoma: Etiology and Current and Future Drugs. Journal of Clinical and Experimental Hepatology 9:2, pages 221-232.
Crossref
Crossref
Qin Ning, Ting Wu, Hai-Bin Su, Ke Ma, Jun-Ying Qi, Ming Ni & Di Wu. 2019. Acute Exacerbation of Chronic Hepatitis B. Acute Exacerbation of Chronic Hepatitis B
371
455
.
Changjiang Liu, Li Wang, Huizhong Xie, Liyuan Zhang, Bingshu Wang, Chun Luo, Suiqun Wang, Mingliang Tang, Zhongbiao Fu, Hailan Ruan, Zhengjin Liu, Ling Wei, Wenyi Yi & Yunqian Xie. (2018) The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection. PLOS ONE 13:11, pages e0206060.
Crossref
Crossref
Maria Guido. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach
671
678
.
Yi Shen, Sheng Zhang, Xulin Wang, Yuanyuan Wang, Jian Zhang, Gang Qin, Wenchao Li, Kun Ding, Lei Zhang & Feng Liang. (2017) Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta‐analysis. Liver International 37:10, pages 1451-1460.
Crossref
Crossref
Suzanne Polis, Iryna Zablotska-Manos, Amany Zekry & Lisa Maher. (2017) Adherence to Hepatitis B Antiviral Therapy. Gastroenterology Nursing 40:3, pages 239-246.
Crossref
Crossref
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenDarren J. Wong, Stephen A. Locarnini & Alexander J.V. Thompson. 2016. Clinical Virology. Clinical Virology
713
770
.
Brendon K. Luvisa & Tarek I. Hassanein. (2016) Hepatitis B Virus Infection and Liver Decompensation. Clinics in Liver Disease 20:4, pages 681-692.
Crossref
Crossref
Luciano Sobrevals, Mónica Enguita, Jorge Quiroga, Jesús Prieto & Puri Fortes. (2016) Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats. PLOS ONE 11:9, pages e0162955.
Crossref
Crossref
M. Granato, C. Zompetta, E. Vescarelli, C. Rizzello, A. Cardi, S. Valia, G. Antonelli, C. Marchese, M. R. Torrisi, A. Faggioni & M. Cirone. (2016) HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2. Scientific Reports 6:1.
Crossref
Crossref
Jian Zhang, Yi Shen, Hui Cai, Yan-Mei Liu & Gang Qin. (2015) Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis. Hepatology Research 45:11, pages 1100-1109.
Crossref
Crossref
Frank A.J.A. Bodewes, Hubert P.J. van der Doef, Roderick H.J. Houwen & Henkjan J. Verkade. (2015) Increase of Serum γ-Glutamyltransferase Associated With Development of Cirrhotic Cystic Fibrosis Liver Disease. Journal of Pediatric Gastroenterology & Nutrition 61:1, pages 113-118.
Crossref
Crossref
Maria Buti, Scott Fung, Edward Gane, Nezam H. Afdhal, Robert Flisiak, Selim Gurel, John F. Flaherty, Eduardo B. Martins, Leland J. Yee, Phillip Dinh, Jeffrey D. Bornstein, G. Mani Subramanian, Harry L. A. Janssen, Jacob George & Patrick Marcellin. (2015) Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatology International 9:2, pages 243-250.
Crossref
Crossref
Hiroshi Fukui. (2015) Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?. World Journal of Gastroenterology 21:41, pages 11584.
Crossref
Crossref
Daisuke Hasegawa, Michael C. Wallace & Scott L. Friedman. 2015. Stellate Cells in Health and Disease. Stellate Cells in Health and Disease
41
62
.
Victoria Arama, Hakan Leblebicioglu, Krzysztof Simon, Jean Pierre Zarski, Claus Niederau, François Habersetzer, Johannes Vermehren, Wieslawa Bludzin, Mariana Jinga, Sercan Ulusoy, Isabelle Klauck, Edith Morais, Stefan Bjork, Benedicte Lescrauwaet, Driss Kamar, Stefan Zeuzem, Patrick Marcellin, Danielle Botta-Fridlund, Stanislas Pol, Marianne Maynard, François Habersetzer, Xavier Causse, Laurent Alric, Pauline Simo Noumbissie, Stefan Mauss, Guido Gerken, Tobias Goeser, Manfred Wiese, Heiner Busch, Lothar Schneider, Jens Schubert, Meike Brenner, Inka Scheffrahn, Andrzej Dziambor, Dariusz Goryszewski, Barbara Postawa-Klosinska, Jerzy Sieklucki, Robert Pleśniak, Monica Acalovschi, Coman Tanasescu, Lucian Raducan, Ioan Sporea, Mihai Voiculescu, Olimpia Chira, Sorin Stefan Arama, Mihaela Andreea Radulescu, Adriana Nicolau, Doina Nitescu, Daniela Ioana Munteanu, Andrei Nanu, Isabel Dan, Diana Nicolita, Camelia Ionescu, Monica Ecobici, Gina Micu, Raluca Irinel Parepa, Andra Suceveanu, Gaye Usluer, Mevlut Baskol, Resat Ozaras, Saban Esen, Elif Doyuk Kartal & Tansu Yamazhan. (2013) Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies. Antiviral Therapy 19:3, pages 245-257.
Crossref
Crossref
Kalman Tokes, Syed Quadri, Patrick Cahill, Grace Chiu, Angel Ivanov & Hong Tang. (2013) Disease and Treatment Perceptions Among Asian Americans Diagnosed with Chronic Hepatitis B Infection. Journal of General Internal Medicine 29:3, pages 477-484.
Crossref
Crossref
Vincenza Calvaruso & Antonio Craxì. (2014) Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?. Liver International 34, pages 85-90.
Crossref
Crossref
Yun-Fan Liaw. (2013) Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy. Journal of Hepatology 59:4, pages 880-881.
Crossref
Crossref
Zachary D. Goodman. (2013) Hepatopathology of hepatitis B. Clinical Liver Disease 2:1, pages 49-51.
Crossref
Crossref